Christel Vangestel Selected Research

Christel Vangestel Research Topics

Disease

29	Neoplasms (Cancer) 04/2022 - 10/2009
12	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2009
7	Hypoxia (Hypoxemia) 08/2019 - 10/2009
4	Neoplasm Metastasis (Metastasis) 01/2017 - 10/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 04/2010
2	Adenocarcinoma 01/2021 - 11/2016
2	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2017
2	Necrosis 01/2017 - 10/2011
1	Primitive Neuroectodermal Tumors (PNET) 03/2016
1	Breast Neoplasms (Breast Cancer) 07/2014
1	Body Weight (Weight, Body) 11/2011
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2011
1	Anemia 10/2009

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 04/2022 - 07/2014
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2009
5	Caspase 3 (Caspase-3)IBA 01/2017 - 04/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
4	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 04/2010
3	Gemcitabine FDA Link 01/2021 - 04/2016
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 04/2012
3	duramycinIBA 01/2018 - 12/2015
2	Everolimus FDA Link 01/2021 - 03/2016
2	UAMC-2526IBA 01/2021 - 01/2017
2	Monoclonal AntibodiesIBA 03/2020 - 09/2019
2	micaIBA 03/2020 - 09/2019
2	Metformin (Glucophage)FDA LinkGeneric 08/2019 - 01/2019
2	conatumumabIBA 01/2018 - 04/2017
2	Oxygen (Dioxygen)IBA 09/2017 - 10/2009
2	technetium 99m HYNIC-duramycinIBA 04/2017 - 01/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2016
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2016 - 07/2014
2	Plasminogen Activator Inhibitor 1IBA 11/2016 - 07/2014
2	Annexin A5IBA 04/2012 - 11/2011
2	Bevacizumab (Avastin)FDA Link 04/2012 - 11/2011
1	Denosumab FDA Link 04/2022
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 04/2022
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2020
1	Proline (L-Proline)FDA Link 07/2020
1	Serine Proteases (Serine Protease)IBA 07/2020
1	CyclooctanesIBA 03/2020
1	Radioisotopes (Radionuclides)IBA 03/2020
1	3- fluoro- 2- (4- ((2- nitro- 1H- imidazol- 1- yl)methyl)- 1H- 1,2,3- triazol- 1- yl)propan- 1- olIBA 08/2019
1	Therapeutic UsesIBA 08/2019
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	AntibodiesIBA 09/2017
1	Immunoglobulin G (IgG)IBA 04/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	EndopeptidasesIBA 01/2017
1	thymidine kinase 1IBA 01/2017
1	Serine (L-Serine)FDA Link 01/2017
1	Thymidine PhosphorylaseIBA 01/2017
1	Thymidylate SynthaseIBA 01/2017
1	ZincIBA 01/2017
1	alovudineIBA 01/2017
1	Colchicine FDA LinkGeneric 11/2016
1	fluoromisonidazoleIBA 01/2016
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2016
1	deoxyuridine triphosphateIBA 01/2016
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2014
1	Hypoxia-Inducible Factor 1IBA 01/2013
1	Hydralazine (Apresoline)FDA LinkGeneric 01/2013
1	technetium 99m tricarbonyl His-annexin A5IBA 04/2012
1	Technetium (Technetium 99m)IBA 04/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	CollagenIBA 11/2011
1	pimonidazoleIBA 11/2011
1	Carbonic Anhydrase IXIBA 04/2010
1	Carbonic AcidIBA 04/2010
1	Carbon DioxideIBA 04/2010
1	Biological ProductsIBA 10/2009
1	Erythropoietin FDA Link 10/2009

Therapy/Procedure

13	Therapeutics 01/2021 - 10/2009
6	Drug Therapy (Chemotherapy) 01/2021 - 11/2011
5	Radiotherapy 08/2019 - 10/2009
3	Aftercare (After-Treatment) 04/2017 - 11/2011
3	Secondary Prevention 04/2017 - 01/2017
1	Immunotherapy 04/2022
1	Electrodes (Electrode) 10/2009